Charles Schwab’s Bionano Genomics BNGO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-467
| Closed | -$19K | – | 3512 |
|
2024
Q2 | $19K | Hold |
467
| – | – | ﹤0.01% | 3593 |
|
2024
Q1 | $31.1K | Hold |
467
| – | – | ﹤0.01% | 3407 |
|
2023
Q4 | $52.9K | Hold |
467
| – | – | ﹤0.01% | 3398 |
|
2023
Q3 | $84.8K | Sell |
467
-1,699
| -78% | -$309K | ﹤0.01% | 3367 |
|
2023
Q2 | $793K | Sell |
2,166
-1,480
| -41% | -$542K | ﹤0.01% | 2843 |
|
2023
Q1 | $2.43M | Sell |
3,646
-20
| -0.5% | -$13.3K | ﹤0.01% | 2470 |
|
2022
Q4 | $3.21M | Buy |
3,666
+133
| +4% | +$116K | ﹤0.01% | 2408 |
|
2022
Q3 | $3.88M | Buy |
3,533
+60
| +2% | +$65.9K | ﹤0.01% | 2353 |
|
2022
Q2 | $2.88M | Sell |
3,473
-41
| -1% | -$34K | ﹤0.01% | 2436 |
|
2022
Q1 | $5.44M | Buy |
3,514
+99
| +3% | +$153K | ﹤0.01% | 2238 |
|
2021
Q4 | $6.13M | Buy |
3,415
+178
| +5% | +$319K | ﹤0.01% | 2245 |
|
2021
Q3 | $10.7M | Buy |
3,237
+2,069
| +177% | +$6.83M | ﹤0.01% | 1970 |
|
2021
Q2 | $5.14M | Buy |
1,168
+1,057
| +952% | +$4.65M | ﹤0.01% | 2342 |
|
2021
Q1 | $538K | Buy |
+111
| New | +$538K | ﹤0.01% | 3053 |
|